S-adenosylmethionine levels in the diagnosis of Pneumocystis carinii pneumonia in patients with HIV infection

Clinical Infectious Diseases

Volumn 46, Issue 3, 2008, Pages 467-471

  Skelly, Michael J ^a   Holzman, Robert S ^b   Merali, Salim ^c  

^a LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; COTRIMOXAZOLE; S ADENOSYLMETHIONINE;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TIME SERIES ANALYSIS;

ADULT; HIV INFECTIONS; HUMANS; PNEUMOCYSTIS CARINII; PNEUMONIA, PNEUMOCYSTIS; PROSPECTIVE STUDIES; S-ADENOSYLMETHIONINE; TUBERCULOSIS, PULMONARY;

EID: 39349092380     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/525854     Document Type: Article

References (23)

1. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30(Suppl 1):S5-14.
2. Ruffini DD, Madhi SA. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. Aids 2002; 16:105-12.
3. Barry SM, Johnson MA. Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management. HIV Med 2001; 2:123-32.
4. Chiang PK, Gordon RK, Tal J, et al. S-adenosylmethionine and methylation. Faseb J 1996; 10:471-80.
5. Merali S, Frevert U, Williams JH, Chin K, Bryan R, Clarkson AB Jr. Continuous axenic cultivation of Pneumocystis carinii. Proc Natl Acad Sci U S A 1999; 96:2402-7.
6. Merali S, Vargas D, Franklin M, Clarkson AB Jr. S-adenosylmethionine and Pneumocystis carinii. J Biol Chem 2000; 275:14958-63.
7. Finkelstein J. Methionine metabolism in mammals. J Nutr Biochem 1990; 1:228-37.
8. Merali S, Clarkson AB Jr, S-adenosylmethionine and Pneumocystis. FEMS Microbiology Letters 2004; 237:179-86.
9. Skelly M, Hoffman J, Fabbri M, Holzman RS, Clarkson AB Jr, Merali S. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet 2003; 361:1267-8.
10. Greenberg A, Rimal B, Felner K, et al. S-adenosylmethionine as a biomarker for the early detection of lung cancer. Chest 2007; 132:1247-52.
11. Loehrer FM, Angst CP, Brunner FP, Haefeli WE, Fowler B. Evidence for disturbed S-adenosylmethionine:S-adenosylhomocyteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant 1998; 13:656-61.
12. Corrales F, Cabrero C, Pajares MA, Ortiz P, Martin-Duce A, Mato JM. Inactivation and dissociation of S-adenosylmethionine synthetase by modification of sulfhydryl groups and its possible occurrence in cirrhosis. Hepatology 1990; 11:216-22.
13. Ferre N, Gomez F, Camps J, et al. Plasma homocysteine concentrations in patients with liver cirrhosis. Clin Chem 2002; 48:183-5.
14. Ideo G. S-adenosylmethionine levels in hepatic cirrhosis. Minerva Medica 1975; 66:1571-80.
15. Nguyen TT, Hayakawa T, Tsuge H. Effect of vitamin B6 deficiency on the synthesis and accumulation of S-adenosylhomocysteine and S-adenosylmethionine in rat tissues. J Nutr Sci Vitaminol 2001; 47:188-94.
16. Poirier LA, Wise CK, Delongchamp RR, Sinha R. Blood determinations of S-adneosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet. Cancer Epidemiol Biomarkers Prev 2001; 10:649-55.
17. Becker A, Smulders YM, et al. S-adenosylcysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin, and vitamin B6 concentrations. Eur J Clin Invest 2003; 33:17-25.
18. Loehrer FM, Schwab R, Angst CP, Haefeli WE, Fowler B. Influence of oral S-adenosylmethionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine, and methionine in healthy humans. J Pharmacol Exp Ther 1997; 282:845-50.
19. Loehrer FM, Haefeli WE, Angst CP, Browne G, Frick G, Fowler B. Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans. Clin Sci 1996; 91:79-86.
20. Bell KM, Potkin SG, Carreon D, Pion L. S-adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurol Scand Suppl 1994; 154:15-8.
21. Muller T, Fowler B, Kuhn W. Levodopa intake increases plasma levels of S-adenosylmethionine in treated patient with Parkinson's disease. Clin Neuropharmacol 2005; 28:274-6.
22. Muller T, Woitalla D, Hauptmann B, Fowler B, Kuhn W. Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease. Neurosci Lett 2001; 308:54-6.
23. Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest 2007; 131:1173-80.